ClinicalTrials.gg
Not yet recruitingNCT06727786Updated Dec 11, 2024

Serious Game to Teach Opioid Overdose Response

A Phase 2 interventional study of Serious game training in Opioid Overdose, sponsored by University of Nevada, Reno. Not yet recruiting. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-11.

Sponsored by University of Nevada, Reno · Phase 2, Interventional, and Other

Phase
Phase 2
Study type
Interventional
Enrollment
850
Allocation
Randomized
Ages
12 Years and older
Sex
All
01

Study summary

This study evaluates the efficacy of a serious game to teach students how to recognize and respond to opioid overdose

Read the detailed description

This study uses an interactive realistic film depicting an opioid overdose to teach high school/middle school students how to recognize and respond to opioid overdose. The film features a person who finds their friend unresponsive, with evidence of opioid use. The unresponsive friend demonstrates signs of opioid overdose. The hero must recognize opioid overdose, administer naloxone (opioid antedote) and perform CPR. The film is made interactive by the narrator pausing the action of the film, and asking learners to answer questions/make choices.

Efficacy is tested on the day of training, and 2-4 months later. Efficacy is measured by student ability to correctly administer naloxone to a manikin, perform CPR, and answer knowledge questions about opioid overdose. Other studied metrics include student engagement/enjoyment, attitudes/biases, and emotions created by the training. These will be tested through validated questionnaires.

02

Conditions studied

  • Opioid Overdose

Browse trials for

03

In context

Opiate Overdose

70 studies on the registry are indexed under Opiate Overdose; 11 are open to participants now.

This study's planned enrollment of 850 is above the median of 184 across 48 interventional studies indexed under Opiate Overdose.

Browse Opiate Overdose studies →

Lead sponsor

University of Nevada, Reno is the lead sponsor of 28 studies on the registry; 5 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Student at participating school, enrolled in Health or Science Class

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Phase 2
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
850 participants (estimated)

Study arms

  • No intervention
    Control

    No intervention/training

  • Experimental
    Serious Game

    Serious Game training to respond to opioid overdose

    Other: Serious game training

Interventions

  • OtherSerious game training

    A serious game featuring a dramatic/realistic film, pauses with questions for active learning, and practice administration of naloxone and performing CPR

06

What researchers measure

Primary outcomes

  1. Naloxone administration Skill

    Properly administer naloxone to a victim of opioid overdose Study personnel will ask students to administer naloxone to a CPR manikin. Personnel will use a checklist from the Center for Addiction and Mental Health to score student responses.

    Time frame: Day of training, and 2-3 months

Secondary outcomes

  1. CPR Skill

    Ability to perform high-quality CPR Students will be asked to perform CPR on a CPR manikin for 2 minutes. CPR skill will be measured with the CPR Meter 2 from Laerdal, which reports compression rate, depth, and percent recoil. We will consider "high quality CPR" students who perform 70% or more of compressions at appropriate rate (100-120/min), depth (2-2.5inches), and full recoil.

    Time frame: Day of training, and 2-3 months

  2. Attitudes towards opioid overdose

    Attitudes, enjoyment, and emotions towards opioid overdose Emotions will be measured using the PANAS scale (Positive And Negative Affect Scale) which consists of 10 positive and 10 negative emotion words. The total score is calculated by finding the sum of the 10 positive items, and then the 10 negative items. Scores range from 10 - 50 for both sets of items. For the total positive score, a higher score indicates more of a positive affect. Engagement and enjoyment will be measured using Likert-style questions asking for agreement with statements such as "I enjoyed CPR training," "CPR training was fun," "I will use CPR training in the future," "It is important to learn CPR" Attitudes will be measured with a custom questionnaire asking Likert-style responses to statements regarding opioid overdose.

    Time frame: Day of training, and 2-3 months

  3. Knowledge of opioid overdose response

    Knowledge of how to recognize and respond to opioid overdose A questionnaire of custom-created multiple choice questions will assess student knowledge of how to recognize and respond to opioid overdose.

    Time frame: Day of training, and 2-3 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Participants are minors and therefore protected. No IDP will be shared

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06727786
Lead sponsor
University of Nevada, Reno
Responsible party
Sponsor
First posted
Dec 11, 2024
Start date
Feb 1, 2026 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Dec 11, 2024

Study contacts

Associate Professor, MD
Contact
ltoft@unr.edu
7756828239

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion